Positive effect of restrictions on antibiotic consumption
Positive effect of restrictions on antibiotic consumption
Background/aim: This study aimed to examine the change in the etiology of hospital infections with restricting and releasing of group2 carbapenems (G2C) (meropenem/imipenem/doripenem).Materials and methods: This study was planned in three periods. Study period 1 (SP-1): Carbapenems were prescribed withoutrestriction by infectious disease specialists. SP-2: G2C prescription was restricted. SP-3: Carbapenem prescription was released.Results: In total, 4443 cases [1053 in SP-1 (23.7%), 1332 in SP-2 (29.9%), and 2085 in SP-3 (46.9%)] were included in the study. Infectionrates were 11%, 6.5%, and 7.9% in SP-1, SP-2, and SP-3, respectively (P = 0.001). Acinetobacter spp.-related hospital infection rates were3.9%, 1.2%, and 1.8%, in SP-1, SP-2, and SP-3, respectively (P = 0.0001). Infection related mortality in SP-1, SP-2, and SP-3 was 7.3%,5%, and 3.8%, respectively (P = 0.001).Conclusion: Hospital-acquired Acinetobacter infections, antibiotic consumption, and infection-related mortality were decreasedsignificantly with the restriction of G2C. Positive behaviors that were obtained during the restricted period were continued with releaseof restriction.
___
- Jung JY, Park MS, Kim SE, Park BH, Son JY, Kim EY, Lim
JE, Lee SK, Lee SH, Lee KJ et al. Risk factors for multi-drug
resistant Acinetobacter baumannii bacteremia in patients with
colonization in the intensive care unit. BMC Infect Dis 2010;
10: 2-11.
- Aldeyab MA, Kearney MP, Scott MG, Aldiab MA, Alahmadi
YM, Darwish Elhajji FW, Magee FA, McElnay JC. An
evaluation of the impact of antibiotic stewardship on reducing
the use of high-risk antibiotics and its effect on the incidence of
Clostridium difficile infection in hospital settings. J Antimicrob
Chemoth 2012; 67: 2988-2996.
- Lima AL, Oliveira PR, Paula AP, Dal-Paz K, Almeida JN Jr,
Félix Cda S, Rossi F. Carbapenem stewardship – positive
impact on hospital ecology. Braz J Infect Dis 2011; 15: 1-5.
- Mozes J, Ebrahimi F, Goracz O, Miszti C, Kardos G. Effect
of carbapenem consumption patterns on the molecular
epidemiology and carbapenem resistance of Acinetobacter
baumannii. J Med Microbiol 2014; 63: 1654-1662.
- Chen CY, Tien FM, Sheng WH, Huang SY, Yao M, Tang JL,
Tsay W, Tien HF, Hsueh PR. Clinical and microbiological
characteristics of bloodstream infections among patients with
haematological malignancies with and without neutropenia
at a medical centre in northern Taiwan, 2008–2013. Int J
Antimicrob Ag 2017; 49: 272-281.
- Beriş FŞ, Budak EE, Gülek D, Uzun A, Çizmeci Z, Mengeloğlu
FZ, Direkel Ş, Çetinkol Y, Ay Altıntop Y, Iraz M et al. Investigation
of the frequency and distribution of beta-lactamase genes in
the clinical isolates of Acinetobacter baumannii collected from
different regions of Turkey: a multicenter study. Mikrobiyol
Bul 2016; 50: 511-521.
- Nemli SA, Demirdal T. Acinetobacter baumannii Suşlarında
Antibiyotik Direncindeki Değişimin Değerlendirilmesi. 6.
Türkiye EKMUD bilimsel platformu poster sunumları; 4–8
Nisan 2017; Antalya, Türkiye. Mediterranean Journal of
Infection, Microbes and Antimicrobials 2017; 6: 45-169.
- Ministry of Health of Turkey Republic. Hospital Infections
Report (UHESA). Website http://hizmetstandartlari.saglik.gov.
tr/Eklenti/2815,2014-ulusal-ozet-rapor-1pdf.pdf?0 [accessed
27 January 2017].
- Guclu E, Ogutlu A, Karabay O, Demirdal T, Erayman I,
Hosoglu S, Turhan V, Erol S, Oztoprak N, Batirel A et al.
Antibiotic consumption in Turkish hospitals; a multi-centre
point prevalence study. J Chemotherapy 2016; 9478: 1-6.
- Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu
M. Effects of carbapenem consumption on the prevalence of
Acinetobacter infection in intensive care unit patients. Ann
Clin Microb Anti 2014; 13: 7.
- Cheon S, Kim M, Yun S, Moon JY, Kim Y. Controlling endemic
multidrug-resistant Acinetobacter baumannii in Intensive Care
Units using antimicrobial stewardship and infection control.
Korean J Intern Med 2016; 31: 367-374.
- WHO Collaborating Centre for Drug Statistics Methodology.
Guidelines for ATC classification and DDD assignment,
2018. Oslo, Norway, 2017. Website https://www.whocc.no/
filearchive/publications/guidelines.pdf [accessed 23 January
2018].
- Centers for Disease Control and Prevention. CDC/NHSN
National Healthcare Safety Network (NHSN). Patient Safety
Component Manual. Website https://www.cdc.gov/nhsn/
pdfs/pscmanual/pcsmanual_current.pdf [accessed 23 January
2018].
- Türe Yüce Z, Alp E. Infection control bundles for the prevention
of hospital infections. Mediterranean Journal of Infection,
Microbes and Antimicrobials 2016; 5: 8.
- Busani S, Serafini G, Mantovani E, Venturelli C, Giannella
M, Viale P, Mussini C, Cossarizza A, Girardis M. Mortality in
patients with septic shock by multidrug resistant bacteria. J
Intensive Care Med 2017: 88506661668816.
- Goff DA, Karam GH, Haines ST. Impact of a national
antimicrobial stewardship mentoring program: Insights and
lessons learned. Am J Health-Syst Ph 2017; 74: 224-231.
- Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger
M, Andremont A, Lucet JC, Yazdanpanah Y. Hand hygiene,
cohorting, or antibiotic restriction to control outbreaks of
multidrug-resistant Enterobacteriaceae. Infect Cont Hosp Ep
2016; 37: 272-280.
- Hum RS, Cato K, Sheehan B, Patel S, Duchon J, DeLaMora P,
Ferng YH, Graham P, Vawdrey DK, Perlman J et al. Developing
clinical decision support within a commercial electronic health
record system to improve antimicrobial prescribing in the
neonatal ICU. Appl Clin Inform 2014; 5: 368-387.
- Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown
E, Gould IM, Ramsay CR, Michie S. Interventions to improve
antibiotic prescribing practices for hospital inpatients. In:
Davey P, editor. Cochrane Database of Systematic Reviews.
Chichester, UK: John Wiley & Sons, Ltd; 2013.